ADAP
Adaptimmune Therapeutics
ADAP
ADAP
86 hedge funds and large institutions have $663M invested in Adaptimmune Therapeutics in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 12 closing their positions.
Holders
86
Holders Change
+10
Holders Change %
+13.16%
% of All Funds
1.97%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
22
Increased
20
Reduced
26
Closed
12
Calls
$2.08M
Puts
$654K
Net Calls
+$1.43M
Net Calls Change
+$1.69M